Recently, our pacing and electrophysiology team performed a special catheter ablation surgery for multiple patients with paroxysmal supraventricular tachycardia - atrial fibrillation cryoablation surgery. It is reported that this technology is the first to be carried out in the Rizhao area, marking a new level of diagnosis and treatment for arrhythmia in our hospital.
In recent years, atrial fibrillation cryoablation has gradually become the preferred method for high-risk target ablation surgery in the field of arrhythmia treatment. Our pacing and electrophysiology team, led by Dr. Xie Xinxing, Deputy Chief Physician of Cardiology, Medical Doctor, and Master's Supervisor at Qingdao University, continuously innovates and develops multiple new technologies in the region, allowing arrhythmia patients in Rizhao and surrounding areas to enjoy high-quality diagnosis and treatment services right at their doorstep.
Professional diagnosis and development of treatment plans
Recently, Mr. Li, 58 years old, came to the Cardiology Department of Qingdao University Affiliated Rizhao Hospital/Rizhao Heart Disease Hospital for treatment due to repeated palpitations and fainting. After a series of examinations, it was diagnosed as paroxysmal atrial fibrillation. Due to the occurrence of syncope every time palpitations occur, considering Mr. Li's poor heart function and poor surgical tolerance. After multiple discussions, the pacing and electrophysiology team suggested that he undergo atrial fibrillation cryoablation surgery, which has a shorter surgical time and less pain for patients compared to radiofrequency ablation.
"Compared to radiofrequency ablation, cryoablation for atrial fibrillation has stronger operability, does not require complex 3D modeling and point by point ablation, greatly saving surgical time and high success rate. Moreover, it has fewer complications, especially esophageal fistula, pericardial tamponade and other complications, which are greatly reduced compared to radiofrequency ablation and have higher safety. The surgical time is shorter, and it is more suitable for the elderly and patients with heart failure." Director Jie Xinxing introduced.
Heart saving, solving the problem of atrial fibrillation
Atrial fibrillation cryoablation is a minimally invasive catheterization technique that involves puncturing the root of the thigh and placing a catheter of ordinary ballpoint pen core thickness into the heart to treat arrhythmia.
Atrial fibrillation cryoablation can release frozen energy at the site where the left atrium is connected to the pulmonary vein, forming a barrier. In this way, abnormal discharge caused by pulmonary veins will be limited within the isolation zone, ensuring that correct instructions can be conveyed to the atrium and ventricle.
Interventional in the operating room, medical staff quickly confirmed the location of the lesion with their rich experience in catheter ablation. Under the leadership of Director Xie Xinxing, the team performed cryoablation on Mr. Li with exquisite and mature medical technology. Within more than an hour, the lesion was accurately cleared, and Mr. Li recovered well after surgery. He could resume normal activities the next day.
Ms. Zhang, who was also undergoing atrial fibrillation cryoablation treatment in the hospital, said in an interview, "Finally, there is no longer the feeling of a particularly fast heartbeat before the surgery. It almost jumps to the throat, and after a while, it immediately stops. Thank you so much to the medical staff of Rizhao Heart Disease Hospital. This is the place where the people truly trust their hearts!"
To do everything in one's power to safeguard one's health
Thanks to the implementation of centralized procurement of medical consumables for cardiac intervention electrophysiology in our hospital, patients who underwent atrial fibrillation cryoablation surgery saved 10-2000 yuan in surgical costs compared to before during discharge settlement. Qingdao University Affiliated Rizhao Hospital/Rizhao Heart Disease Hospital provided partial cost subsidies to patients who needed surgery for atrial fibrillation and/or atrial flutter, further alleviating the medical burden on patients. Director Xie Xinxing said, "For rapid arrhythmias such as atrial fibrillation, atrial flutter, supraventricular tachycardia, and premature beats, catheter ablation is a very effective treatment method that has a curative effect on most patients. The advantage of catheter radiofrequency ablation is that it can not only treat diseases but also have no drug toxic side effects. In the past, due to relatively high surgical costs and low awareness, now centralized procurement is implemented, and more patients can dispel economic doubts and choose to undergo surgery."
At the same time, in order to further address patient pain and alleviate the significant medical burden on urban and rural residents, Qingdao University Affiliated Rizhao Hospital/Rizhao Heart Disease Hospital provides partial medical fund subsidies to patients with atrial fibrillation and/or atrial flutter who require electrophysiological surgery. The medical expenses incurred by patients during hospitalization, after deducting medical insurance, will be reimbursed through commercial insurance. The portion of the expenses that individuals need to bear after medical assistance will be borne by the Love Assistance Special Fund of Qingdao University Affiliated Rizhao Hospital/Rizhao Heart Disease Hospital.
Professional team, forging a healthy defense line
As a non-profit hospital designated by the national medical insurance network, Dr. Jie Xinxing has led a team of arrhythmia experts to actively carry out clinical new technologies and projects since the hospital was put into use, promoting the establishment of the first atrial fibrillation outpatient clinic in the Rizhao area.
The team is particularly skilled in radiofrequency ablation of rapid arrhythmias, pacemaker treatment of slow arrhythmias and partial heart failure, and interventional diagnosis and treatment of difficult, critical, and complex coronary heart disease. Continuously developing new clinical diagnosis and treatment technologies, leading the region in the development of three-dimensional mapping assisted radiofrequency ablation for the treatment of various arrhythmias (such as atrial fibrillation, atrial flutter, premature ventricular contractions, ventricular tachycardia, etc.), left atrial appendage occlusion for the prevention of atrial fibrillation stroke, and physiological pacing technology. In the past, people with cardiovascular diseases often went to major hospitals such as Beijing and Shanghai for medical consultation. Now, they can enjoy the services of top domestic cardiovascular experts at their doorstep, allowing the people of Rizhao to truly achieve the goal of "not leaving the market with heart disease" to protect their health and become a place for patients to trust with confidence.
If you have a heart disease and don't go out of the market, protect the people with sincerity
Since the hospital was put into use, the cardiology department has routinely carried out various clinical new technologies such as atrial fibrillation radiofrequency ablation guided by Pentaray mapping catheters, left atrial appendage occlusion, left bundle branch pacemaker implantation, lead free cardiac pacemaker implantation, intravascular ultrasound, OCT, FFR examination, forward and reverse intervention technology for chronic occlusive lesions, coronary rotation milling, cutting balloon, drug eluting balloon, biodegradable stent implantation, etc., all of which have achieved good social benefits. At present, the intervention treatment of complex coronary artery lesions in hospitals has become normalized, and the intervention level has reached first-class in the province, which has attracted many patients. In the past, seeking medical treatment and consultation at major hospitals such as Beijing and Shanghai was tiring, but now you can see top domestic cardiovascular experts at your doorstep. A hospital that has risen from the ground has truly enabled the people of Rizhao to achieve the goal of "not leaving the market due to heart disease", guarding the local people and truly becoming a place for patients to trust with confidence.
